This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
HTLV-1 infection of donor-derived T cells might promote acute graft-versus-host disease following liver transplantation
Nature Communications Open Access 30 November 2022
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Berger SP, Roos A, Daha MR . Complement and the kidney: what the nephrologist needs to know in 2006. Nephrol Dial Transplant 2005; 20: 2613–2619.
Feucht HE . Complement C4d in graft capillaries—the missing link in the recognition of humoral alloreactivity. Am J Transplant 2003; 3: 646–652.
Crespo-Leiro MG, Veiga-Barreiro A, Domenech N, Paniagua MJ, Pinon P, Gonzalez-Cuesta M et al. Humoral heart rejection (severe allograft dysfunction with no signs of cellular rejection or ischemia): incidence, management and the value of C4d for diagnosis. Am J Transplant 2005; 5: 2560–2564.
Asplund S, Gramlich TL . Chronic mucosal changes of the colon in graft-versus-host disease. Mod Pathol 1998; 11: 513–515.
Thompson B, Salzman D, Steinhauer J, Lazenby AJ, Wilcox CM . Prospective endoscopic evaluation for gastrointestinal graft-versus-host disease: determination of the best diagnostic approach. Bone Marrow Transplant 2006; 38: 371–376.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zhang, P., Wilkerson, M. & Schworer, C. C4d staining is a valuable marker in identifying chronic GVHD in colonic biopsies following BMT. Bone Marrow Transplant 42, 209–211 (2008). https://doi.org/10.1038/bmt.2008.132
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2008.132
This article is cited by
-
A prospective phase 2 clinical trial of a C5a complement inhibitor for acute GVHD with lower GI tract involvement
Bone Marrow Transplantation (2023)
-
HTLV-1 infection of donor-derived T cells might promote acute graft-versus-host disease following liver transplantation
Nature Communications (2022)